# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The data could potentially bolster Novo's case for Wegovy as it attempts to convince insurers and governments to cover the...
Novo Nordisk's Phase 3a trial demonstrates a significant reduction in bleeding episodes with Mim8 treatment for hemophilia ...
https://ml-eu.globenewswire.com/Resource/Download/be52a7ec-2630-49c0-b374-88ae71352c87
This is not the first time the tech mogul has seemingly backed the blockbuster drug. Last year, Musk claimed that Ozempic was a...
To gain an edge, this is what you need to know today.